Nymox Pharmaceutical
NYMX
#10757
Rank
NZ$33.21 M
Marketcap
Country
NZ$0.36
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -NZ$3.79 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$11.88 Million, an increase over its 2021 earnings that were of -NZ$22.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$3.79 Million-68.09%
2022 -NZ$11.88 Million-47.71%
2021 -NZ$22.72 Million6.61%
2020 -NZ$21.31 Million-10.91%
2019 -NZ$23.92 Million24.24%
2018 -NZ$19.25 Million-20.03%
2017 -NZ$24.07 Million2.71%
2016 -NZ$23.44 Million-63.86%
2015 -NZ$64.85 Million674.44%
2014 -NZ$8.38 Million-6.11%
2013 -NZ$8.92 Million-35.66%
2012 -NZ$13.87 Million-20.76%
2011 -NZ$17.5 Million38.33%
2010 -NZ$12.65 Million35.59%
2009 -NZ$9.33 Million11.8%
2008 -NZ$8.35 Million-12.94%
2007 -NZ$9.59 Million8.85%
2006 -NZ$8.81 Million36.5%
2005 -NZ$6.45 Million-4.4%
2004 -NZ$6.75 Million-14.58%
2003 -NZ$7.9 Million
2001 -NZ$5.8 Million-20.54%
2000 -NZ$7.3 Million21.72%
1999 -NZ$5.99 Million-25.56%
1998 -NZ$8.05 Million101.3%
1997 -NZ$4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.06 B-866,411.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.68 B-322,543.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.13 B-334,112.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.27 B-1,609,040.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.71 B-69,142.11%๐Ÿ‡บ๐Ÿ‡ธ USA